NOV Stock Analysis: NOV | NYSE
Oil & Gas Equipment & Services | NYSE, USA | Market Cap: 6.726m USD | 12M Return: 46% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 78.0M
EPS Trend: -62.3%
Qual. Beats: 0
Rev. Trend: 59.5%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
NOV Inc. (formerly National Oilwell Varco) is a global provider of systems, components, and products serving the oil and gas drilling and production industry, along with industrial and renewable energy markets. Founded in 1862 and headquartered in Houston, Texas, the company operates through two segments: Energy Equipment and Energy Products and Services. Its offerings span drill bits, downhole tools, completion equipment (including frac plugs and sleeves), artificial lift systems, drilling rigs (land and offshore), tubular goods, subsea solutions, processing/separations equipment, and pumps used across the upstream, midstream, and renewable energy value chains.
The company is classified within the GICS Energy sector, specifically the Oil & Gas Equipment & Services sub-industry, and trades as a mid-cap stock on the NYSE. Its diversified product portfolio-covering drilling rigs, capital equipment for hydraulic stimulation and coiled tubing, marine construction, and composite pipe-positions it as a broad-based supplier to energy operators and industrial customers rather than a pure-play services contractor.
- US rig count rebound drives consumables and drill bit revenue
- Energy Equipment backlog expansion signals offshore capex recovery
- Share repurchases and debt reduction accelerate capital returns
| Net Income: 92.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -3.62 > 1.0 |
| NWC/Revenue: 39.17% < 20% (prev 40.85%; Δ -1.68% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.09b > Net Income 92.0m |
| Net Debt (1.62b) to EBITDA (735.0m): 2.21 < 3 |
| Current Ratio: 2.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (364.0m) vs 12m ago -4.96% < -2% |
| Gross Margin: 19.54% > 18% (prev 22.67%; Δ -3.13% > 0.5%) |
| Asset Turnover: 77.56% > 50% (prev 78.22%; Δ -0.66% > 0%) |
| Interest Coverage Ratio: 4.28 > 6 (EBIT TTM 377.0m / Interest Expense TTM 88.0m) |
| A: 0.31 (Total Current Assets 5.72b - Total Current Liabilities 2.32b) / Total Assets 11.1b |
| B: -0.06 (Retained Earnings -687.0m / Total Assets 11.1b) |
| C: 0.03 (EBIT TTM 377.0m / Avg Total Assets 11.2b) |
| D: 1.27 (Book Value of Equity 6.21b / Total Liabilities 4.88b) |
| Altman-Z'' = 3.37 = A |
| DSRI: 0.94 (Receivables 2.30b/2.47b, Revenue 8.69b/8.82b) |
| GMI: 1.16 (GM 22.67% / 19.54%) |
| AQI: 0.98 (AQ_t 0.26 / AQ_t-1 0.27) |
| SGI: 0.99 (Revenue 8.69b / 8.82b) |
| TATA: -0.09 (NI 92.0m - CFO 1.09b) / TA 11.1b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of July 14, 2026, the stock is trading at USD 19.13 with a total of 2,032,865 shares traded. Over the past week, the price has changed by +4.83%, over one month by -10.60%, over three months by -2.92% and over the past year by +46.01%.
Current recommended Stop Loss: 17.30 (which is 9.6% or 2.9 ATR below the current price).
NOV has received a consensus analysts rating of 3.54. Therefore, it is recommended to hold NOV.
- StrongBuy: 5
- Buy: 7
- Hold: 9
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 21.8 | 14% |
P/E Trailing = 72.0769
P/E Forward = 20.0
P/S = 0.7737
P/B = 1.0278
P/EG = 1.1062
Revenue TTM = 8.69b USD
EBIT TTM = 377.0m USD
EBITDA TTM = 735.0m USD
Long Term Debt = 1.69b USD (from longTermDebt, last quarter)
Short Term Debt = 127.0m USD (from shortTermDebt, last quarter)
Debt = 2.96b USD (from shortLongTermDebtTotal, last quarter) + Leases 624.0m
Net Debt = 1.62b USD (calculated: Debt 2.96b - CCE 1.34b)
Enterprise Value = 8.35b USD (6.73b + Debt 2.96b - CCE 1.34b)
Interest Coverage Ratio = 4.28 (Ebit TTM 377.0m / Interest Expense TTM 88.0m)
EV/FCF = 11.37x (Enterprise Value 8.35b / FCF TTM 734.0m)
FCF Yield = 8.79% (FCF TTM 734.0m / Enterprise Value 8.35b)
FCF Margin = 8.44% (FCF TTM 734.0m / Revenue TTM 8.69b)
Net Margin = 1.06% (Net Income TTM 92.0m / Revenue TTM 8.69b)
Gross Margin = 19.54% ((Revenue TTM 8.69b - Cost of Revenue TTM 6.99b) / Revenue TTM)
Gross Margin QoQ = 18.47% (prev 20.29%)
Tobins Q-Ratio = 0.75 (Enterprise Value 8.35b / Total Assets 11.1b)
Interest Expense / Debt = 2.97% (Interest Expense 88.0m / Debt 2.96b)
Taxrate = 42.86% (15.0m / 35.0m)
NOPAT = 215.4m (EBIT 377.0m * (1 - 42.86%))
Current Ratio = 2.47 (Total Current Assets 5.72b / Total Current Liabilities 2.32b)
Debt / Equity = 0.48 (Debt 2.96b / totalStockholderEquity, last quarter 6.21b)
Debt / EBITDA = 2.21 (Net Debt 1.62b / EBITDA 735.0m)
Debt / FCF = 2.21 (Net Debt 1.62b / FCF TTM 734.0m)
Total Stockholder Equity = 6.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.82% (Net Income 92.0m / Total Assets 11.1b)
RoE = 1.45% (Net Income TTM 92.0m / Total Stockholder Equity 6.36b)
RoCE = 4.68% (EBIT 377.0m / Capital Employed (Equity 6.36b + L.T.Debt 1.69b))
RoIC = 2.53% (NOPAT 215.4m / Invested Capital 8.52b)
WACC = 7.48% (E(6.73b)/V(9.69b) * Re(10.03%) + D(2.96b)/V(9.69b) * Rd(2.97%) * (1-Tc(0.43)))
Discount Rate = 10.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.61 | Cagr: -3.78%
[DCF] Terminal Value 73.10% ; FCFF base≈900.8m ; Y1≈789.9m ; Y5≈638.2m
[DCF] Fair Price = 24.03 (EV 10.2b - Net Debt 1.62b = Equity 8.62b / Shares 358.9m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -62.28 | EPS CAGR: -58.79% | SUE: -0.15 | # QB: 0
Revenue Correlation: 59.55 | Revenue CAGR: 2.09% | SUE: 0.08 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.16 | Chg30d=+1.39% | Revisions=-25% | Analysts=13
EPS next Quarter (2026-09-30): EPS=0.25 | Chg30d=+0.53% | Revisions=-25% | Analysts=13
EPS current Year (2026-12-31): EPS=0.80 | Chg30d=+0.86% | Revisions=-25% | GrowthEPS=+104.3% | GrowthRev=-1.6%
EPS next Year (2027-12-31): EPS=1.27 | Chg30d=+0.31% | Revisions=-40% | GrowthEPS=+59.7% | GrowthRev=+5.4%
[Analyst] Revisions Ratio: -62% (up=0, down=5)